#VELA Vela Technologies Investee – #SKL Skillcast – Grant of Share Options June 23, 2022 – Posted in: Blog, Vela Technologies Plc (VELA)

Skillcast Group plc (AIM: SKL), the provider of content and technology for digital compliance transformation, announces the grant of 360,000 share options (the “EMI Options”) over ordinary shares of 0.1 pence each (“Ordinary Shares”) to Richard Steele, Chief Financial Officer, under the Skillcast Group plc EMI Share Option Plan. The EMI Options have an exercise price of 24 pence per option, being the closing mid-market price of an Ordinary Share on 22 June 2022, the…

Continue reading

#ORPH Open Orphan Plc – £1.5m Contract renewal for Venn Life Sciences November 15, 2021 – Posted in: Blog, Open Orphan (ORPH)

(AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials , announces that Venn Life Sciences (“Venn”), a subsidiary of Open Orphan, has signed a contract renewal with a major global pharmaceutical client worth £1.5m over two years. The renewed contract will commence in January 2022, with the Venn team in Breda providing dedicated clinical pharmacokinetics (‘PK’) support to this leading global pharmaceutical client on an array of drug development programmes, to study…

Continue reading